Vivo Capital, LLC Cyma Bay Therapeutics, Inc. Transaction History

Vivo Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $2.48 Million - $3.83 Million	-585,394 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $8.62 Million - $13.6 Million	-1,503,962 Reduced 71.98%	585,394 $3.36 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $1.43 Million - $4.3 Million	1,011,889 Added 93.91%	2,089,356 $7.29 Million
Q1 2020 May 15, 2020	BUY	$1.25 - $2.02 $1.35 Million - $2.18 Million	1,077,467 New	1,077,467 $1.6 Million
Q3 2019 Nov 13, 2019	SELL	$5.12 - $7.21 $11 Million - $15.5 Million	-2,154,934 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.05 - $13.66 $598,550 - $1.35 Million	98,934 Added 4.81%	2,154,934 $15.4 Million
Q1 2019 May 14, 2019	BUY	$8.16 - $13.42 $9.38 Million - $15.4 Million	1,150,000 Added 126.93%	2,056,000 $27.3 Million
Q2 2018 Aug 10, 2018	BUY	$10.66 - $14.38 $1.13 Million - $1.52 Million	106,000 Added 13.25%	906,000 $12.2 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $7.2 Million - $12.1 Million	800,000 New	800,000 $10.4 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.